X-Feed Billboard (International)
The newsboard processes news from the NASDAQ Nordic portfolio company GlobeNewswire, which provides investors with company-relevant information. This relates in particular to events that may be relevant to the listing of companies or tradable financial instruments.
GlobNewswire (formerly PrimeNewswire) specializes in public relations solutions and digital media services. This feed adds another important source of information for investors to the popular X-Billboard portfolio.
Annual General Meeting of April 30, 2025
Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race
When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
Sanofi inaugure en France sa nouvelle unité d’excellence R&D Vaccins
Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)
Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors
Chlamydia vaccine candidate granted fast track designation by the US FDA
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Sanofi successfully prices EUR 1.5 billion of bond issue
Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
Sanofi lance la tournée de Zeus, le cheval métallique de la cérémonie d’ouverture
The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.
RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.
Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.
On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.